Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Subscribe to see Cassidy Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cassidy Bio is a drug discovery company headquartered in Israel. Its most recent funding round, Seed, raised $8M in November 2025. Xcout tracks 8 named people at Cassidy Bio, including Rom Kshuk (CEO).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Cassidy Bio, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $8M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Cassidy Bio's closest competitors — see the full list of competitors and alternatives →
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Syntax Bio is a biotechnology research company headquartered in Chicago, Illinois, focused on synthetic biology. The company utilizes its proprietary Cellgorithm CRISPR-based platform to program stem cells and accelerate the development of next-generation organoids and cell-derived therapies.
Coding Bio is an Oxford-based biotechnology company that combines a high-throughput wet lab and machine learning platform to screen, build, and deliver fully-assembled modular therapies like CARs and BiTEs.
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Eurus Therapeutics is a biotechnology startup headquartered in Fujisawa, Kanagawa Prefecture, Japan. Founded in 2021, the company is building an advanced drug-discovery platform based on a novel genome-editing technology called Eurus Editor.
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cassidy Bio? Suggest a correction · Work at Cassidy Bio? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.